| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |